Sterlington Advises Avanos Medical Management Team on $1.27 Billion Acquisition

NEW YORK--(BUSINESS WIRE)--Sterlington advises Avanos Medical management team on $1.27 billion acquisition.

Business Wire • Jul 29, 2026

Avanos Medical, Inc. Stockholders Approve Acquisition by American Industrial Partners

ALPHARETTA, Ga., July 22, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos" or the "Company"), a leading medical technology company, today announced that its stockholders have voted to approve the pending acquisition of Avanos by affiliates of investment funds advised by American Industrial Partners ("AIP") at a special meeting of stockholders (the "Special Meeting") held earlier today.

PRNewsWire • Jul 22, 2026

Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600

NEW YORK, July 20, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600

PRNewsWire • Jul 20, 2026

Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger

ALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced the receipt of all required regulatory approvals to complete the pending acquisition of Avanos by affiliates of investment funds advised by AIP (the "Merger").

PRNewsWire • Jul 2, 2026

Avanos Medical Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avanos Medical, Inc. - AVNS

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. Under the terms of the proposed transaction, shareholders of Avanos will receive $25.00 in cash for each share of Avanos that they own. KSF is seeking to determine whether this consideration and the process that led to i.

Business Wire • Jun 24, 2026

Reasons to Retain Avanos Medical Stock in Your Portfolio for Now

AVNS' SNS momentum, Nexus Medical integration and AIP deal support growth, but tariff costs, margin pressure and PM&R weakness remain headwinds.

Zacks Investment Research • Jun 24, 2026

Avanos Medical (AVNS) Up 1.1% Since Last Earnings Report: Can It Continue?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Jun 4, 2026

New Strong Sell Stocks for May 15th

AVNS, BKR and CAG have been added to the Zacks Rank #5 (Strong Sell) List on May 15th, 2026.

Zacks Investment Research • May 15, 2026

Deciphering Avanos Medical (AVNS) International Revenue Trends

Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Zacks Investment Research • May 11, 2026

AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down

Avanos Medical tops Q1 revenue estimates on strong SNS growth, but margin pressure and PM&R weakness weigh on earnings and profitability.

Zacks Investment Research • May 7, 2026